SPOK vs VEON
Spok Holdings, Inc. and Veon Ltd., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | SPOK | VEON |
|---|---|---|
| Revenue | $139.7M | $4.4B |
| Net income | $15.9M | $591.0M |
| Gross margin | 78.7% | · |
| Net margin | 11.4% | 13.4% |
| Return on equity | 10.5% | · |
| Diluted EPS | $0.75 | $0.30 |
| Dividend / share | $1.25 | $0.00 |
| Payout ratio | 171.6% | · |
| Free cash flow | $25.2M | · |
| Equity | $146.4M | $1.3B |
| Net debt / equity | · | 1.05× |
| Current ratio | 1.18× | · |
| Revenue CAGR 5y | −1.2% | 4.8% |
| Profit CAGR 5y | · | · |
VEON bills 31.5× the revenue of SPOK, and keeps more of each dollar of revenue as profit (13.4% against 11.4%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | SPOK | VEON |
|---|---|---|
| FY2025 | $139.7M | $4.4B |
| FY2024 | $137.7M | $4.0B |
| FY2023 | $139.0M | $3.7B |
| FY2022 | $134.5M | $3.8B |
| FY2021 | $142.2M | $3.9B |
| FY2020 | $148.2M | $3.5B |
| FY2019 | $160.3M | $8.1B |
| FY2018 | $169.5M | $9.1B |
| FY2017 | $171.2M | $9.5B |
| FY2016 | $179.6M | $8.9B |
Bottom line
| Fiscal year | SPOK | VEON |
|---|---|---|
| FY2025 | $15.9M | $591.0M |
| FY2024 | $15.0M | $487.0M |
| FY2023 | $15.7M | $-2.5B |
| FY2022 | $21.9M | $-9.0M |
| FY2021 | $-22.2M | $801.0M |
| FY2020 | $-44.2M | $-316.0M |
| FY2019 | $-10.8M | $683.0M |
| FY2018 | $-1.5M | $362.0M |
| FY2017 | $-15.3M | $-534.0M |
| FY2016 | $14.0M | $2.4B |
11 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$4,259,292,000 | VEON |
| FY2024 | −$3,866,347,000 | VEON |
| FY2023 | −$3,558,975,000 | VEON |
| FY2022 | −$3,620,466,000 | VEON |
| FY2021 | −$3,707,847,000 | VEON |
| FY2020 | −$3,333,820,000 | VEON |
| FY2019 | −$7,928,711,000 | VEON |
| FY2018 | −$8,916,526,000 | VEON |
| FY2017 | −$9,302,825,000 | VEON |
| FY2016 | −$8,705,439,000 | VEON |
| FY2015 | −$9,416,372,000 | VEON |
VEON has reported the higher revenue in every one of these 11 fiscal years. The gap has narrowed since the earliest year compared.
11 of 17 comparable fiscal years — a year missing data on either side is not counted.
11 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −2.1 pp | VEON |
| FY2024 | −1.3 pp | VEON |
| FY2023 | +77.5 pp | SPOK |
| FY2022 | +16.5 pp | SPOK |
| FY2021 | −36.4 pp | VEON |
| FY2020 | −20.8 pp | VEON |
| FY2019 | −15.2 pp | VEON |
| FY2018 | −4.9 pp | VEON |
| FY2017 | −3.3 pp | VEON |
| FY2016 | −19.5 pp | VEON |
| FY2015 | +48.1 pp | SPOK |
The higher net margin has changed hands between SPOK and VEON over this period.
11 of 17 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
VEON's net margin has been more volatile than SPOK's over the 11 comparable fiscal years — 23.6 percentage points of standard deviation against 18.1.
11 of 17 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between SPOK and VEON over these 11 fiscal years — SPOK led in 3 and VEON in 8.
11 of 17 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
VEON's return on equity has been more volatile than SPOK's over the 3 comparable fiscal years — 29.0 percentage points of standard deviation against 13.2.
3 of 17 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between SPOK and VEON over these 3 fiscal years — SPOK led in 2 and VEON in 1.
3 of 17 comparable fiscal years — a year missing data on either side is not counted.